Yousif Capital Management LLC Reduces Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Yousif Capital Management LLC lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 18.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,927 shares of the biotechnology company’s stock after selling 2,954 shares during the period. Yousif Capital Management LLC’s holdings in Axon Enterprise were worth $3,339,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. BKM Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth about $32,000. Key Financial Inc raised its stake in Axon Enterprise by 367.6% in the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after buying an additional 125 shares in the last quarter. Lindbrook Capital LLC raised its stake in Axon Enterprise by 43.3% in the fourth quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after buying an additional 52 shares in the last quarter. Rakuten Securities Inc. purchased a new stake in Axon Enterprise in the fourth quarter worth about $48,000. Finally, Provence Wealth Management Group bought a new stake in Axon Enterprise during the 3rd quarter valued at approximately $80,000. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of research reports. Barclays boosted their target price on shares of Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a report on Thursday, February 29th. JMP Securities upped their price objective on shares of Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 6th. Robert W. Baird lifted their target price on shares of Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, February 22nd. StockNews.com downgraded Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. Finally, Argus assumed coverage on Axon Enterprise in a research report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price target for the company. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $314.91.

Axon Enterprise Stock Performance

Shares of AXON opened at $308.23 on Monday. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87. The business has a fifty day moving average of $304.22 and a 200 day moving average of $262.21. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The firm has a market capitalization of $23.26 billion, a P/E ratio of 134.01 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.29. The firm had revenue of $432.14 million for the quarter, compared to analysts’ expectations of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. As a group, sell-side analysts anticipate that Axon Enterprise, Inc. will post 2.44 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.